Thiamylal (Surital) is a barbiturate derivative invented in the 1950s. It has sedative, anticonvulsant, and hypnotic effects, and is used as a strong but short acting sedative. Thiamylal is still in current use, primarily for induction in surgical anaesthesia[2] or as an anticonvulsant to counteract side effects from other anaesthetics.[3] It is the thiobarbiturate analogue of secobarbital.
Clinical data | |
---|---|
Other names | Thiamylal, Thioseconal, Surital |
AHFS/Drugs.com | International Drug Names |
ATCvet code |
|
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Metabolism | Hepatic |
Elimination half-life | 14.3 h (cats) |
Identifiers | |
| |
CAS Number |
|
PubChem CID |
|
IUPHAR/BPS |
|
DrugBank |
|
ChemSpider |
|
UNII |
|
KEGG |
|
ChEBI |
|
ChEMBL |
|
CompTox Dashboard (EPA) |
|
ECHA InfoCard | 100.000.927 |
Chemical and physical data | |
Formula | C12H18N2O2S |
Molar mass | 254.35 g·mol−1 |
3D model (JSmol) |
|
| |
| |
(verify) |